Bausch Health
BHC
#3491
Rank
$3.15 B
Marketcap
$8.52
Share price
-2.80%
Change (1 day)
25.41%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : $21.50 Billion USD

According to Bausch Health 's latest financial reports the company's total debt is $21.50 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31$22.38 B7.81%
2022-12-31$20.76 B-8.33%
2021-12-31$22.65 B-5.31%
2020-12-31$23.92 B-7.61%
2019-12-31$25.89 B6.54%
2018-12-31$24.30 B-4.48%
2017-12-31$25.44 B-14.75%
2016-12-31$29.84 B-4.04%
2015-12-31$31.10 B104.16%
2014-12-31$15.23 B-12.34%
2013-12-31$17.37 B57.62%
2012-12-31$11.02 B65.78%
2011-12-31$6.65 B80.18%
2010-12-31$3.69 B840.99%
2009-12-31$0.39 B515.83%
2008-12-31$63.7 M
2006-12-31$0.41 B-6.03%
2005-12-31$0.43 B-8.79%
2004-12-31$0.47 B-41.06%
2003-12-31$0.81 B8.72%
2002-12-31$0.74 B1519.01%
2001-12-31$46.16 M-93.75%
2000-12-31$0.73 B437.24%
1999-12-31$0.13 B8.36%
1998-12-31$0.12 B2489.8%
1997-12-31$4.9 M-30%
1996-12-31$7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$0.26 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA